Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J York

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Nature|November 28, 2019
An acute immune response underlies the benefit of cardiac stem cell therapyRonald J Vagnozzi, Marjorie Maillet, Michelle A Sargent, et al.
Circulation Research|December 4, 2010
Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growthIzhak Kehat, Jennifer Davis, Malte Tiburcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
A specialized population of Periostin-expressing cardiac fibroblasts contributes to postnatal cardiomyocyte maturation and innervationLuis Hortells, Iñigo Valiente-Alandi, Zachary M Thomas, et al.
The Pediatric Infectious Disease Journal|March 15, 2016
A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US AdolescentsDerek Muse, Shane Christensen, Prakash Bhuyan, et al.
Vaccine|December 29, 2015
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workersDavid M Reiner, Prakash Bhuyan, Joseph J Eiden, et al.
The Pediatric Infectious Disease Journal|February 3, 2016
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus VaccineShelly Senders, Prakash Bhuyan, Qin Jiang, et al.
Expert Review of Vaccines|June 9, 2018
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccineJohn L Perez, Judith Absalon, Johannes Beeslaar, et al.
Journal of General Internal Medicine|July 27, 2025
A Qualitative Evaluation of Factors Influencing the Lung Cancer Screening Program Navigator RoleLucy B Spalluto, Kemberlee Bonnet, David Schlundt, et al.
Emerging Infectious Diseases|October 2, 2014
Human babesiosis, Maine, USA, 1995-2011Robert P Smith, Susan P Elias, Timothy J Borelli, et al.
Vaccine|February 17, 2019
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescentsTimo Vesikari, Lars Østergaard, Johannes Beeslaar, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Nature|November 28, 2019
An acute immune response underlies the benefit of cardiac stem cell therapyRonald J Vagnozzi, Marjorie Maillet, Michelle A Sargent, et al.
Circulation Research|December 4, 2010
Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growthIzhak Kehat, Jennifer Davis, Malte Tiburcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
A specialized population of Periostin-expressing cardiac fibroblasts contributes to postnatal cardiomyocyte maturation and innervationLuis Hortells, Iñigo Valiente-Alandi, Zachary M Thomas, et al.
The Pediatric Infectious Disease Journal|March 15, 2016
A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US AdolescentsDerek Muse, Shane Christensen, Prakash Bhuyan, et al.
Vaccine|December 29, 2015
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workersDavid M Reiner, Prakash Bhuyan, Joseph J Eiden, et al.
The Pediatric Infectious Disease Journal|February 3, 2016
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus VaccineShelly Senders, Prakash Bhuyan, Qin Jiang, et al.
Expert Review of Vaccines|June 9, 2018
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccineJohn L Perez, Judith Absalon, Johannes Beeslaar, et al.
Journal of General Internal Medicine|July 27, 2025
A Qualitative Evaluation of Factors Influencing the Lung Cancer Screening Program Navigator RoleLucy B Spalluto, Kemberlee Bonnet, David Schlundt, et al.
Emerging Infectious Diseases|October 2, 2014
Human babesiosis, Maine, USA, 1995-2011Robert P Smith, Susan P Elias, Timothy J Borelli, et al.
Vaccine|February 17, 2019
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescentsTimo Vesikari, Lars Østergaard, Johannes Beeslaar, et al.
Pageof 27